Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 59-66

  Peng, Dacheng ^a   Hiipakka, Richard A ^a   Reardon, Catherine A ^b   Getz, Godfrey S ^b   Liao, Shutsung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Hypertriglyceridemia; LXRs

Indexed keywords

COLLAGEN; LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FOAM CELL; HYPERTRIGLYCERIDEMIA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; DNA-BINDING PROTEINS; FOAM CELLS; GENE EXPRESSION REGULATION; HYDROCARBONS, FLUORINATED; HYPERTRIGLYCERIDEMIA; LIPIDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SINUS OF VALSALVA; SULFONAMIDES;

EID: 60649088062     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.058     Document Type: Article

References (22)

1. Cao G., Liang Y., Jiang X.C., and Eacho P.I. Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect 17 (2004) 35-41
2. Repa J.J., Turley S.D., Lobaccaro J.A., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
3. Wang N., Ranalletta M., Matsuura F., Peng F., and Tall A.R. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 26 (2006) 1310-1316
4. Yancey P.G., Yu H., Linton M.F., and Fazio S. A pathway-dependent on ApoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells. Arterioscler Thromb Vasc Biol 27 (2007) 1123-1131
5. Zelcer N., and Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116 (2006) 607-614
6. Joseph S.B., McKilligin E., Pei L., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99 (2002) 7604-7609
7. Terasaka N., Hiroshima A., Koieyama T., et al. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 536 (2003) 6-11
8. Levin N., Bischoff E.D., Daige C.L., et al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 25 (2005) 135-142
9. Schultz J.R., Tu H., Luk A., et al. Role of LXRs in control of lipogenesis. Genes Dev 14 (2000) 2831-2838
10. Grefhorst A., Elzinga B.M., Voshol P.J., et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277 (2002) 34182-34190
11. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000) 943-949
12. Watanabe M., Houten S.M., Wang L., et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113 (2004) 1408-1418
13. Reardon C.A., Blachowicz L., Lukens J., Nissenbaum M., and Getz G.S. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol 23 (2003) 1449-1454
14. Yoshikawa T., Shimano H., Yahagi N., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277 (2002) 1705-1711
15. Gao Z.G., Choi H.G., Shin H.J., et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int J Pharm 161 (1998) 75-86
16. Reardon C.A., Blachowicz L., White T., et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21 (2001) 1011-1016
17. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
18. Tangirala R.K., Bischoff E.D., Joseph S.B., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 99 (2002) 11896-11901
19. Zhu M., Fu Y., Hou Y., et al. Laminar shear stress regulates liver X receptor in vascular endothelial cells. Arterioscler Thromb Vasc Biol 28 (2008) 527-533
20. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
21. Blaschke F., Leppanen O., Takata Y., et al. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ Res 95 (2004) 110-123
22. VanderLaan P.A., Reardon C.A., and Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24 (2004) 12-22